NCT05631184

Brief Summary

The goal of this clinical trial is to examine the effects of self-administered acupressure intervention for alleviating depressive symptoms among people with depression. It is hypothesized that the self-administered acupressure group would have a great improvement in depressive symptoms as measured by the Patient Health Questionnaire compared with the mental health education group across the 12-week intervention period. The main questions it aims to answer are:

  • Is the self-administered acupressure intervention more effective for alleviating depression and other related outcomes compared to the mental health education group among depressed individuals?
  • Is the self-administered acupressure intervention acceptable and feasible for depressed individuals to alleviate depression? Participants will be randomized into self-administered acupressure group or mental health education group based on the group allocation with a 1:1 ratio. Participants will attend two weekly 120-min self-administered acupressure training or mental health education, respectively.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 30, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

December 15, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

2.5 years

First QC Date

November 14, 2022

Last Update Submit

February 27, 2024

Conditions

Keywords

DepressionAcupressureRandomized Controlled Trial

Outcome Measures

Primary Outcomes (4)

  • Patient Health Questionnaire (PHQ)

    The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27.

    It will be measured at baseline

  • Patient Health Questionnaire (PHQ)

    The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27.

    It will be measured at week 4 from baseline

  • Patient Health Questionnaire (PHQ)

    The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27.

    It will be measured at week 8 from baseline

  • Patient Health Questionnaire (PHQ)

    The PHQ-9, a self-rated questionnaire to assess depressive symptoms over the last 2 weeks on a scale of 0 (not at all) to 3 (nearly every day), with a total score ranging from 0 to 27.

    It will be measured at week 12 from baseline

Secondary Outcomes (20)

  • Hamilton Depression Rating Scale (HDRS)

    It will be measured at baseline

  • Hamilton Depression Rating Scale (HDRS)

    It will be measured at week 4 from baseline

  • Hamilton Depression Rating Scale (HDRS)

    It will be measured at week 8 from baseline

  • Hamilton Depression Rating Scale (HDRS)

    It will be measured at week 12 from baseline

  • The Depression Anxiety Stress Scales (DASS-21) - Stress

    It will be measured at baseline

  • +15 more secondary outcomes

Study Arms (2)

Self-administered acupressure group

EXPERIMENTAL

The participants in the self-administered acupressure group will attend an acupressure training course (2 sessions, 2 h each) to learn self-administered acupressure from an acupuncturist in a classroom at the School Nursing, the Hong Kong Polytechnic University. Each class will be conducted in a small group of 4 to 7 participants to enhance interaction and ensure the quality of teaching. Participants will then practice two times a day for 8 weeks.

Behavioral: Self-administered acupressure group

Mental health education group

ACTIVE COMPARATOR

The participants in the comparison group will receive mental health education group from a registered nurse with the same frequency as those in the treatment group (2 sessions, 2 h each) in a classroom at the School Nursing, the Hong Kong Polytechnic University, and will be reminded to follow the mental health practice daily for 8 weeks.

Behavioral: Mental health education group

Interventions

Self-administered acupressure treatment group was developed on the basis of previous systematic reviews and clinical studies of acupuncture and acupressure for depression. It has robust theoretical basis of TCM. The acupoints selected are commonly used for depression according to a recent systematic review and recommended by other clinical practice guidelines.

Self-administered acupressure group

Mental health education training group was developed based on the materials regarding depression and mental health from the Centre of Health Protection, Department of Health, the Government of Hong Kong SAR and reviewed by a clinical psychologist.

Mental health education group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hong Kong residents aged 18 to 65
  • Can communicate in Cantonese and comprehend written Chinese
  • Have moderate or above-level depression as measured by the PHQ-9 with a score of 10 or above
  • Willing to give informed consent and comply with the trial protocol.

You may not qualify if:

  • Have the PHQ score of 20 or above (referral information to community psychological services will be provided)
  • New onset or change of antidepressant medication or dosage in the last 3 months
  • Previous or current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder as screened using the Chinese version of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders.
  • Have cognitive impairment diagnosed by the Hong Kong Montreal Cognitive Assessment with a score \< 22
  • Skin lesions or infections at the treatment sites
  • Significant suicidal risk as rated by the Hamilton Depression Rating Scale item on suicide (score ≥3)
  • Pregnant or childbearing potential but not using adequate contraception
  • With any major medical condition that causes depression based on the judgement of a psychiatrist.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Nursing, the Hong Kong Polytechnic University

Hong Kong, Hong Kong

RECRUITING

Related Publications (4)

  • Zhang Z, Li S, Meng H, Wang Y, Zhang Y, Wu M, Chen Y, Rong P, Wang Y. Efficacy and safety of acupuncture in the treatment of depression: A systematic review of clinical research. Anat Rec (Hoboken). 2021 Nov;304(11):2436-2453. doi: 10.1002/ar.24783. Epub 2021 Oct 8.

    PMID: 34623754BACKGROUND
  • Fernandez-Chinguel JE, Goicochea-Lugo S, Villarreal-Zegarra D, Taype-Rondan A, Zafra-Tanaka JH. Acupuncture for major depressive disorder: A review of the recommendations stated at clinical practice guidelines. Complement Ther Med. 2020 Mar;49:102321. doi: 10.1016/j.ctim.2020.102321. Epub 2020 Jan 24.

    PMID: 32147048BACKGROUND
  • Cheung DST, Tiwari A, Yeung WF, Yu DSF, So MKP, Chau PH, Wang XM, Lum TYS, Yuk Fung HYK, Ng BYM, Zhang ZJ, Lao L. Self-Administered Acupressure for Caregivers of Older Family Members: A Randomized Controlled Trial. J Am Geriatr Soc. 2020 Jun;68(6):1193-1201. doi: 10.1111/jgs.16357. Epub 2020 Feb 25.

    PMID: 32096884BACKGROUND
  • Kroenke K. Enhancing the clinical utility of depression screening. CMAJ. 2012 Feb 21;184(3):281-2. doi: 10.1503/cmaj.112004. Epub 2012 Jan 9. No abstract available.

    PMID: 22231681BACKGROUND

MeSH Terms

Conditions

DepressionDepressive Disorder

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMood DisordersMental Disorders

Study Officials

  • Wing Fai Yeung, PhD

    the School of Nursing, the Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researchers who perform the assessment and analysis will be blinded to group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm parallel assignment involves two groups of participants. In this study, one group will receive self-administered acupressure, and the other group will receive the mental health education. So during the trial, participants in one group receive self-administered acupressure "in parallel" to participants in the other group, who receive the mental health education.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2022

First Posted

November 30, 2022

Study Start

December 15, 2022

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

The individual participant data will be available when the study has been published. The individual participant data will be available upon request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
No time restriction for the data availability.
Access Criteria
The individual participant data will be available upon request.

Locations